Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.

[1]  Fred S Apple,et al.  Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. , 2012, Clinical chemistry.

[2]  J. Gea,et al.  Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. , 2012, European heart journal.

[3]  S. Nygård,et al.  Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study , 2012, Clinical science.

[4]  S. Yusuf,et al.  High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. , 2011, Clinical chemistry.

[5]  T. Edvardsen,et al.  Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomy. , 2011, The American journal of cardiology.

[6]  H. White Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? , 2011, Journal of the American College of Cardiology.

[7]  Judith S. Hochman,et al.  2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[8]  Hani Jneid,et al.  2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c , 2011, Journal of the American College of Cardiology.

[9]  Eric Boerwinkle,et al.  Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study , 2011, Circulation.

[10]  A. Khera,et al.  Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. , 2010, JAMA.

[11]  M. Zhan,et al.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. , 2010, JAMA.

[12]  H. Kauczor,et al.  Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque , 2010, Heart.

[13]  Mario Plebani,et al.  Recommendations for the use of cardiac troponin measurement in acute cardiac care. , 2010, European heart journal.

[14]  M. Pfeffer,et al.  A sensitive cardiac troponin T assay in stable coronary artery disease. , 2009, The New England journal of medicine.

[15]  M. Sabatine,et al.  Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. , 2008, European heart journal.

[16]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[17]  J. Alpert,et al.  Universal definition of myocardial infarction. , 2007, European heart journal.

[18]  D. Atsma,et al.  Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation , 2007, Pflügers Archiv - European Journal of Physiology.

[19]  M. Pfeffer,et al.  Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. , 2007, Journal of the American College of Cardiology.

[20]  M. Pfeffer,et al.  Angiotensin-converting-enzyme inhibition in stable coronary artery disease. , 2004, The New England journal of medicine.

[21]  J. V. Van Eyk,et al.  Developing the next generation of cardiac markers: disease-induced modifications of troponin I. , 2004, Progress in cardiovascular diseases.

[22]  M. Pencina,et al.  Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation , 2004, Statistics in medicine.

[23]  Carl J Pepine,et al.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients , 2002, Circulation.

[24]  J. Canty,et al.  Preload Induces Troponin I Degradation Independently of Myocardial Ischemia , 2001, Circulation.

[25]  D. Atar,et al.  Extensive Troponin I and T Modification Detected in Serum From Patients With Acute Myocardial Infarction , 2000, Circulation.

[26]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[27]  J. Alpert,et al.  Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction , 2008 .

[28]  D. Petrovic,et al.  Cardiac troponins and left ventricular hypertrophy in hemodialysis patients. , 2008, Clinical laboratory.